Correlation of xenobiotic-metabolizing enzymes, oxidative stress and NFκB signaling with histological grade and menopausal status in patients with adenocarcinoma of the breast

Clinica Chimica Acta

Volumn 411, Issue 5-6, 2010, Pages 368-374

  Vinothini, Govindarajah ^a   Nagini, Siddavaram ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

Breast cancer; Estradiol; Nuclear factor B; Oxidative stress; Xenobiotic metabolizing enzymes

Indexed keywords

CYTOCHROME B5; CYTOCHROME B5 REDUCTASE; CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ADULT; ARTICLE; BREAST ADENOCARCINOMA; CANCER GRADING; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; GENE LOCATION; GENETIC VARIABILITY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MENOPAUSE; OXIDATIVE STRESS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; WESTERN BLOTTING; XENOBIOTIC METABOLISM;

ADENOCARCINOMA; BREAST NEOPLASMS; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; HUMANS; MENOPAUSE; MIDDLE AGED; NEOPLASM STAGING; NF-KAPPA B; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; XENOBIOTICS;

EID: 74849117000     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2009.11.034     Document Type: Article

References (57)

1. Jemal A., Siegel R., Ward E., Murray T., Xu J., and Thun M.J. Cancer statistics. CA Cancer J Clin 58 (2007) 71-96
2. Yeole B.B. Trends in cancer incidence in female breast, cervix uteri, corpus uteri and ovary in India. Asian Pac J Cancer Prev 9 (2008) 119-122
3. Ho C.C., Rohaizak M., Zulkifli S.Z., Siti-Aishah M.A., Nor-Aini U., and Sharifah-Noor-Akmal S.H. Serum sex hormone levels in pre- and postmenopausal breast cancer patients. Singapore Med J 50 (2009) 513-518
4. Hulka B.S., and Moorman P.G. Breast cancer: hormones and other risk factors. Maturitas 61 (2008) 203-213
5. Chen W.Y. Exogenous and endogenous hormones and breast cancer. Best Pract Res Clin Endocrinol Metab 22 (2008) 573-585
6. Eliassen A.H., and Hankinson S.E. Endogenous hormone levels and risk of breast, endometrial and ovarian cancers: prospective studies. Adv Exp Med Biol 630 (2008) 148-165
7. Smetnik V., and Konovalova V. Exogenous sex hormones and risk of breast cancer. Gynecol Endocrinol 16 (2009) 1-3
8. Haas S., Pierl C., Harth V., et al. Expression of xenobiotic and steroid hormone metabolizing enzymes in human breast carcinomas. Int J Cancer 119 (2006) 1785-1791
9. Kumaraguruparan R., Chandra Mohan K.V.P., and Nagini S. Xenobiotic-metabolizing enzymes in patients with adenocarcinoma of the breast: correlation with clinical stage and menopausal status. The Breast 15 (2006) 58-63
10. Tsuchiya Y., Nakajima M., and Yokoi T. Cytochrome-P450 mediated metabolism of estrogens and its regulation in human. Cancer Lett 227 (2005) 115-124
11. Sasaki M., Tanaka Y., Kaneuchi M., Sakuragi N., and Dahiya R. CYP1B1 gene polymorphisms have higher risk for endometrial cancer, and positive correlations with estrogen receptor alpha and estrogen receptor beta expressions. Cancer Res 63 (2003) 3913-3918
12. Bailey L.R., Roodi N., Dupont W.D., and Parl F.F. Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer. Cancer Res 58 (1998) 5038-5041
13. Hanna I.H., Dawling S., Roodi N., Guengerich F.P., and Parl F.F. Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity. Cancer Res 60 (2000) 3440-3444
14. Zarkovic N. 4-Hydroxynonenal as a bioactive marker of pathophysiological processes. Mol Aspects Med 24 (2003) 281-291
15. Meerang M., Nair J., Sirankapracha P., et al. Increased urinary 1, N6-ethenodeoxyadenosine and 3, N4-ethenodeoxycytidine excretion in thalassemia patients: markers for lipid peroxidation-induced DNA damage. Free Radic Biol Med 44 (2008) 1863-1868
16. ε-(hexanonyl) lysine in protein exposed to lipid hydroperoxide. A plausible marker for lipid hydroperoxide-derived protein modification. J Biol Chem 274 (1999) 20406-20414
17. Cheng K.C., Cahill D.S., Kasai H., Nishimura S., and Loeb L.A. 8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G → T and A → C substitutions. J Biol Chem 267 (1992) 166-172
18. Panayiotidis M. Reactive oxygen species (ROS) in multistage carcinogenesis. Cancer Lett 266 (2008) 3-5
19. Kumar A., Takada Y., Boriek A.M., and Aggarwal B.B. Nuclear factor-kappa B: its role in health and disease. J Mol Med 82 (2004) 434-448
20. Sethi G., Sung B., and Aggarwal B.B. Nuclear factor-κ B activation: from bench to bedside. Exp Biol Med 233 (2008) 21-31
21. Rhoads M.G., Kandarian S.C., Pacelli F., Doglietto G.B., and Bossola M. Expression of NF-kappaB and IkappaB proteins in skeletal muscle of gastric cancer patients. Eur J Cancer. 46 (2009) 191-197
22. Frasor J., Weaver A., Pradhan M., et al. Positive cross-talk between estrogen receptor and NF-{kappa}B in breast cancer. Cancer Res. 69 (2009) 8918-8925
23. Himmetoglu S., Dincer Y., Ersoy Y.E., Bayraktar B., Celik V., and Akcay T. DNA oxidation and antioxidant status in breast cancer. J Investig Med 57 (2009) 720-723
24. Elston C.W., and Ellis I.O. Assessment of histological grade. In: Elston C.W., and Ellis O. (Eds). The breast (1998), Edinburgh, New York 356-384
25. Ames B.N., Durston W.E., Yamasaki E., and Lee F.D. Carcinogens are mutagens: a simple test system combining liver homogenates for activation and bacteria for detection. Proc Natl Acad Sci U S A 70 (1973) 2081-2285
26. Omura T., and Sato R. The carbon monoxide binding pigment of liver. J Biol Chem 239 (1964) 2370-2378
27. Burke M.D., and Mayer R.T. Ethoxyresorufin: direct fluorimetric assay of microsomal O-dealkylation, which is preferentially inducible by 3-methylcholanthrene. Drug Metab Dispos 2 (1974) 583-588
28. Habig W.H., Pabst M.J., and Jakoby W.B. Glutathione S-transferases: the first enzymatic step in mercapturic acid formation. J Biol Chem 249 (1974) 7130-7139
29. Ernster L. DT-diaphorase. In: Estabrook R.W., and Pullman M.E. (Eds). Methods Enzymol vol. 10 (1967), Academic Press, New York 309-317
30. Vinothini G., Senthil Murugan R., and Nagini S. Evaluation of molecular markers in a rat model of mammary carcinogenesis. Oncol Res 17 (2009) 483-493
31. Yager J.D., and Davidson N.E. Estrogen carcinogenesis in breast cancer. N Engl J Med 354 (2006) 270-282
32. Wen W., Ren Z., Shu X.O., et al. Expression of cytochrome P450 1B1 and catechol-O-methyltransferase in breast tissue and their associations with breast cancer risk. Cancer Epidemiol Biomarkers Prev 16 (2007) 917-920
33. Murray G.I., Taylor M.C., McFadyen M.C., et al. Tumor-specific expression of cytochrome P450 CYP1B1. Cancer Res 57 (1997) 3026-3031
34. McKay J.A., Melvin W.T., Ah-See A.K., et al. Expression of cytochrome P450 CYP1B1 in breast cancer. FEBS Lett 374 (1995) 270-272
35. Tokizane T., Shiina H., Igawa M., et al. Cytochrome P450 1B1 is overexpressed and regulated by hypomethylation in prostate cancer. Clin Cancer Res. 11 (2005) 5793-5801
36. McFadyen M.C., Cruickshank M.E., Miller I.D., et al. Cytochrome P450 CYP1B1 over-expression in primary and metastatic ovarian cancer. Br J Cancer 85 (2001 Jul 20) 242-246
37. Saini S., Hirata H., Majid S., and Dahiya R. Functional significance of cytochrome P450 1B1 in endometrial carcinogenesis. Cancer Res 69 (2009) 7038-7045
38. Roos P.H., and Bolt H.M. Cytochrome P450 interactions in human cancers: new aspects considering CYP1B1. Expert Opin Drug Metab Toxicol 1 (2005) 187-202
39. Zhang Y., Gaikwad N.W., Olson K., Zahid M., Cavalieri E.L., and Rogan E.G. Cytochrome P450 isoforms catalyze formation of catechol estrogen quinones that react with DNA. Metabolism 56 (2007) 887-894
40. Bolton J.L., and Thatcher G.R. Potential mechanisms of estrogen quinone carcinogenesis. Chem Res Toxicol 21 (2008) 93-101
41. Kumaraguruparan R., Kabalimoorthy J., and Nagini S. Correlation of lipid peroxidation and antioxidants with clinical stage and menopausal status in patients with adenocarcinoma of the breast. Clin Biochem 38 (2005) 154-158
42. Kang D.H. Oxidative stress, DNA damage, and breast cancer. AACN Clin Issues 13 (2002) 540-549
43. Ruiz-Ramos R., Lopez-Carrillo L., Rios-Perez A.D., De Vizcaya-Ruíz A., and Cebrian M.E. Sodium arsenite induces ROS generation, DNA oxidative damage, HO-1 and c-Myc proteins, NF-kappaB activation and cell proliferation in human breast cancer MCF-7 cells. Mutat Res 674 (2009) 109-115
44. Turpaev K.T. Reactive oxygen species and regulation of gene expression. Biochemistry (Mosc) 67 (2002) 281-292
45. Chang C.S., Chen W.N., Lin H.H., Wu C.C., and Wang C.J. Increased oxidative DNA damage, inducible nitric oxide synthase, nuclear factor kappaB expression and enhanced antiapoptosis-related proteins in Helicobacter pylori-infected non-cardiac gastric adenocarcinoma. World J Gastroenterol 10 (2004) 2232-2240
46. Albright C.D., Klem E., Shah A.A., and Gallagher P. Breast cancer cell-targeted oxidative stress: enhancement of cancer cell uptake of conjugated linoleic acid, activation of p53, and inhibition of proliferation. Exp Mol Pathol 79 (2005) 118-125
47. Biswas D.K., Singh S., Shi Q., Pardee A.B., and Iglehart J.D. Crossroads of estrogen receptor and NF-kappaB signaling. Sci STKE 2005 (2005) 27
48. Singh S., Shi Q., Bailey S.T., et al. Nuclear factor-kappaB activation: a molecular therapeutic target for estrogen receptor-negative and epidermal growth factor receptor family receptor-positive human breast cancer. Mol Cancer Ther 6 (2007) 1973-1982
49. Ping B., He X., Xia W., et al. Cytoplasmic expression of p21CIP1/WAF1 is correlated with IKKbeta overexpression in human breast cancers. Int J Oncol 29 (2006) 1103-1110
50. Park S.A., Na H.K., Kim E.H., Cha Y.N., and Surh Y.J. 4-hydroxyestradiol induces anchorage-independent growth of human mammary epithelial cells via activation of IkappaB kinase: potential role of reactive oxygen species. Cancer Res 69 (2009) 2416-2424
51. Clarkson R. IkB kinase alpha: a link in the chain of the mammary cycle. Breast Cancer Res 4 (2002) 173-175
52. Vinothini G, Balachandran C, Nagini S. Evaluation of molecular markers in canine mammary tumors: correlation with histological grading. Oncol Res in press, doi:10.3727/096504009X12596189659042.
53. Schmidt K.N., Amstad P., Cerutti P., and Baeuerle P.A. The roles of hydrogen peroxide and superoxide as messengers in the activation of transcription factor NF-kappa B. Chem Biol. 2 (1995) 13-22
54. Li N., and Karin M. Is NF-kappaB the sensor of oxidative stress?. FASEB J 13 (1999) 1137-1143
55. Chunder N., Mandal S., Basu D., Roy A., Roychoudhury S., and Panda C.K. Deletion mapping of chromosome I in early onset and late onset breast tumors-a comparative study in eastern India. Pathol Res Pract 199 (2003) 313-321
56. Agarwal G., Ramakant P., Forgach E.R., et al. Breast cancer care in developing countries. World J Surg 33 (2009) 2069-2076
57. Chacko P., Joseph T., Mathew B.S., Rajan B., and Pillai M.R. Role of xenobiotic metabolizing gene polymorphisms in breast cancer susceptibility and treatment outcome. Mutat Res 581 (2005) 153-163